The impact of CDA A79C gene polymorphisms on the response and hematologic toxicity in gemcitabine-treated patients: a meta-analysis.
about
FFCD-1004 Clinical Trial: Impact of Cytidine Deaminase Activity on Clinical Outcome in Gemcitabine-Monotherapy Treated PatientsInfluence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment.Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.Severe acute toxicity following gemcitabine administration: A report of four cases with cytidine deaminase polymorphisms evaluation.
P2860
The impact of CDA A79C gene polymorphisms on the response and hematologic toxicity in gemcitabine-treated patients: a meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The impact of CDA A79C gene po ...... ted patients: a meta-analysis.
@ast
The impact of CDA A79C gene po ...... ted patients: a meta-analysis.
@en
type
label
The impact of CDA A79C gene po ...... ted patients: a meta-analysis.
@ast
The impact of CDA A79C gene po ...... ted patients: a meta-analysis.
@en
prefLabel
The impact of CDA A79C gene po ...... ted patients: a meta-analysis.
@ast
The impact of CDA A79C gene po ...... ted patients: a meta-analysis.
@en
P2093
P356
P1476
The impact of CDA A79C gene po ...... ted patients: a meta-analysis.
@en
P2093
Xiangling Wang
Xiuwen Wang
P304
P356
10.5301/JBM.5000076
P577
2014-02-13T00:00:00Z